Marie‐Hélène Delfau‐Larue

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Olivier Hermine, Eva Hoster, Jan Walewski et al. · The Lancet · 2016 · 390 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +10

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

Yen‐Lin Huang, Aurélien de Reyniès, Laurence de Leval et al. · Blood · 2009 · 307 citations · Full text

Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

Paul Evans, Ch Pott, Patricia J.T.A. Groenen et al. · Leukemia · 2006 · 296 citations

B-cell Malignancies, Lymphoid Neoplasia, Hematological Malignancy +7

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Christiane Pott, Eva Hoster, Marie‐Hélène Delfau‐Larue et al. · Blood · 2009 · 267 citations · Full text

Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936

Monika Brüggemann, Harry N White, Philippe Gaulard et al. · Leukemia · 2006 · 236 citations

Lymphoid Neoplasia, Oncology, T-cell Malignancies Report +13